Abiomed (ABMD) Halted Ahead of FDA Meeting on Blood Pumps
- Top 10 News for 8/25 - 8/29: S&P 500's New Record; U.S. Q2 GDP Outpaces Views; Major Mergers Aplenty
- AIG's (AIG) Peter Hancock Assumes CEO Role; Benmosche Becomes Advisor
- Pressure on U.S. to Update Terror Alert System After U.K. Raises Terror Threat Level
- American Airlines Group (AAL)/Orbitz Worldwide (OWW) Reach Agreement; American Airlines Back on Orbitz Sites
- FTC Requests Additional Info from Reynolds American (RAI), Lorillard (LO) on Pending Deal
Abiomed, Inc. (NASDAQ: ABMD) halted ahead of FDA advisory committee meeting over nonroller-type cardiopulmonary bypass blood pumps.
You May Also Be Interested In
- Amicus Therapeutics (FOLD) Lower; Sanofi's Fabry Disease Treatment Receives Orphan Designation
- Interferon Therapy for HCV Still Expected Strong Amid Daklinza Approval - Roth (LGND) (BMY)
- Cobra Electronics Corp (COBR) trading halted for news dissemination
Create E-mail Alert Related CategoriesFDA, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!